New Jersey is currently home to 1712 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New Brunswick, Hackensack, Newark and Morristown. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
NCT05488483
Recruiting
Participants in this study will have Multispectral Optoacoustic Tomography/MSOT imaging of both breasts immediately before their ultrasound-guided breast biopsy procedure begins. After the MSO imaging is completed, participation in the study will end.
Gender:
Female
Ages:
18 years and above
Trial Updated:
10/23/2023
Locations: Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey
Conditions: Breast Cancer, Melanoma
Register for Updates
Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
NCT02962063
Recruiting
The purpose of this study is to test the safety of adding a new drug, durvalumab (also called MEDI4736), to chemoradiation with either FOLFOX/Capeox or carboplatin and paclitaxel, following initial chemotherapy with FOLFOX. The investigators want to find out what effects, good and/or bad, this combination has on the patient and cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/23/2023
Locations: Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
Conditions: Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Register for Updates
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT05785780
Recruiting
This mixed methods study evaluates the effectiveness and feasibility of a multi-level (patient, team, organizations) intervention to optimize CRC screening for patients with diabetes in primary care safety-net settings.
Gender:
All
Ages:
Between 50 years and 74 years
Trial Updated:
10/19/2023
Locations: RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey
Conditions: Colorectal Cancer Screening, Diabetes Mellitus, Type 2
Register for Updates
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
NCT05775094
Recruiting
The purpose of this study is to measure the effect of romosozumab on bone formation and breakdown (resorption) and determine if romosozumab is a safe treatment for osteoporosis and myeloma-related bone disease (MBD) in postmenopausal people with multiple myeloma (MM).
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2023
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
Conditions: Multiple Myeloma, Osteoporosis
Register for Updates
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
NCT05540392
Recruiting
The purpose of this study is to test whether acupuncture can improve nocturia in prostate cancer survivors. This is the first time acupuncture is being studied for nocturia in prostate cancer survivors. Researchers will see if acupuncture is a practical treatment option for prostate cancer survivors with nocturia. The study will also look at the effect acupuncture has on nocturia and other symptoms prostate cancer survivors experience such as insomnia, hot flashes, anxiety, depression, tiredness... Read More
Gender:
Male
Ages:
18 years and above
Trial Updated:
10/19/2023
Locations: Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
Conditions: Survivorship, Prostate Cancer
Register for Updates
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
NCT04322955
Recruiting
The purpose of this study is to determine if the use of immunotherapy nivolumab and the targeted therapy cabozantinib prior to removal of the kidney, will increase the number subjects who are without any visible kidney cancer in their body at some point during the course of treatment.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2023
Locations: The Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Conditions: Kidney Cancer, Renal Cell Carcinoma
Register for Updates
A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis
NCT03465111
Recruiting
ATLAS study is a clinical trial to evaluate the potential role of subcutaneous adrenocorticotropic hormone (ACTH) gel in the management of non-infectious scleritis. Specifically, the ATLAS Study aims to evaluate the safety, tolerability and effect of 2 different dose regimens of ACTH gel administered by subcutaneous (SC) injection in patients with scleritis, over a period of 12 months. Scleritis is an inflammatory disease affecting the sclera (white outer coating of the eye), which causes blur... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2023
Locations: Metropolitan Eye Research and Surgery Institute, Palisades Park, New Jersey
Conditions: Scleritis
Register for Updates
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
NCT01169194
Recruiting
The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population. African Americans with or without Crohn's disease or ulcerative colitis are eligible to join. If you agree to join the study, the investigators will ask for information about your health. The investigators will also ask you to give us a blood sample so that they may discover the genes that cause IBD. The blood sample may be collected at Johns Hop... Read More
Gender:
All
Ages:
5 years and above
Trial Updated:
10/18/2023
Locations: Robert Wood Johnson Medical School, New Brunswick, New Jersey
Conditions: Inflammatory Bowel Disease
Register for Updates
TRE: Microbiome, Metabolic Health and Bone
NCT05548517
Recruiting
In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.
Gender:
Female
Ages:
Between 50 years and 79 years
Trial Updated:
10/17/2023
Locations: Rutgers University - NJ Inst Food Nutrition & Health, New Brunswick, New Jersey
Conditions: Weight Loss, Time Restricted Feeding, Bone Loss
Register for Updates
EASE: The Materna Prep Pivotal Study
NCT03973281
Recruiting
This study is designed to evaluate the safety and effectiveness of the Materna Prep Device in reducing pelvic muscle injuries during vaginal delivery. Subjects are randomized to Materna Prep Device or Standard of Care without use of the Materna Prep Device Intervention with the Materna Prep Device is expected to be a one-time use of approximately 30-90 minutes during the 1st stage of labor. Subject participation in the study is targeted to be 12 months from the time of the use of the device d... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: The Cooper Health System, Camden, New Jersey
Conditions: Vaginal Delivery, Pelvic Organ Prolapse
Register for Updates
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
NCT03860883
Recruiting
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: Cooperman Barnabas Medical Center, Livingston, New Jersey
Conditions: Cutaneous Melanoma, Stage II
Register for Updates
Apply tACS to Alleviate Anxiety Symptoms
NCT06086015
Recruiting
This is a clinical research trial exploring the efficacy of non-invasive neuromodulation (NM) intervention in the treatment of anxiety. The NM used in this study consists of 25 minutes of 5 hz transcranial alternating current stimulation (tACS) titrated up to 2mA targeting the anterolateral amygdala across 12 treatment sessions with a 3-4 week time period. The studied population includes patients with the following anxiety disorders: generalized anxiety disorder (GAD), social anxiety disorder (S... Read More
Gender:
All
Ages:
5 years and above
Trial Updated:
10/16/2023
Locations: NCI Clinical Research Foundation, Mount Arlington, New Jersey
Conditions: Anxiety Disorders
Register for Updates